Cargando…
Development of a Robust Control Strategy for Fixed-Dose Combination Bilayer Tablets with Integrated Quality by Design, Statistical, and Process Analytical Technology Approach
Control strategy and quality by design (QbD) are widely used to develop pharmaceutical products and improve drug quality; however, studies on fixed-dose combination (FDC) bilayer tablets are limited. In this study, the bilayer tablet consisted of high-dose metformin HCl in a sustained-release layer...
Autores principales: | Chun, Myung-Hee, Kim, Ji Yeon, Park, Eun-Seok, Choi, Du Hyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467219/ https://www.ncbi.nlm.nih.gov/pubmed/34575519 http://dx.doi.org/10.3390/pharmaceutics13091443 |
Ejemplares similares
-
Formulation and Evaluation of Fixed-Dose Combination of Bilayer Gastroretentive Matrix Tablet Containing Atorvastatin as Fast-Release and Atenolol as Sustained-Release
por: Dey, Sanjay, et al.
Publicado: (2014) -
Pharmacokinetics of fixed-dose combination of atorvastatin and metformin compared with individual tablets
por: Ghim, Jong-Lyul, et al.
Publicado: (2019) -
Statistical Design of Experiments on Fabrication of Bilayer Tablet of Narrow Absorption Window Drug: Development and In vitro characterisation
por: Jivani, R. R., et al.
Publicado: (2012) -
Bioequivalence of saxagliptin/dapagliflozin fixed‐dose combination tablets compared with coadministration of the individual tablets to healthy subjects
por: Vakkalagadda, Blisse, et al.
Publicado: (2016) -
Capillary electrophoresis for the assay of fixed-dose combination tablets of artesunate and amodiaquine
por: Amin, N’Cho Christophe, et al.
Publicado: (2012)